A detailed history of Mendota Financial Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mendota Financial Group, LLC holds 1 shares of AMGN stock, worth $315. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Holding current value
$315
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$309.38 - $337.38 $309 - $337
1 New
1 $323,000
Q2 2023

Jul 27, 2023

SELL
$214.27 - $253.37 $56,567 - $66,889
-264 Reduced 94.96%
14 $3.11 Million
Q1 2023

Apr 24, 2023

BUY
$225.79 - $275.2 $56,447 - $68,800
250 Added 892.86%
278 $67.2 Million
Q4 2022

Feb 03, 2023

BUY
$229.03 - $291.01 $6,412 - $8,148
28 New
28 $7.35 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.